Gregg L. Mayer, PhD has more than 20 years experience as an entrepreneur, management consultant, and company president in a variety of settings in the healthcare industry.  Gregg received his BA in biology in 1981 and his PhD in physiology in 1987, both from the University of California, Berkeley. 

During his years at UC he was also a co-founder and President of Berkeley Antibody Company, Inc. (BAbCO), a biotechnology services company, now a subsidiary of Covance, Inc.  In 1986, Gregg joined Vivigen, Inc., a Nasdaq company operating the country’s largest prenatal testing business, as Vice President and became President in 1988.  Business Week magazine named Vivigen one of “The Best Small Growth Companies in America” in 1988 and 1989.  Vivigen was later acquired by Genzyme Corporation.

From 1990 to 1992, Gregg moved to Japan to study in the Japanese language program at Keio University in Tokyo. At the same time, he was also a research student at both Keio University’s Graduate School of Business Administration and The National Children’s Hospital Research Center.

After returning to the US in 1993, Gregg joined the San Francisco office of McKinsey & Company where he worked on hospital and managed healthcare projects until 1995, when he established his own management consulting practice.

He has spent the last 12 years focusing on the two largest health care markets in the world, the US and Japan.  Clients include US and Japanese companies in the pharmaceutical, biotechnology, medical device, clinical laboratory, insurance, and managed care sectors.  He was Kaiser Permanente International’s Director for Japan from 1996-1998. 

Gregg is a founding board member of the Disease Management Association of Japan, and the Japan Society for Health Support Sciences, the two leading disease management organizations in Japan.  He is a lecturer and writer about healthcare in both the US and Japan.

Click to view CURRICULUM VITAE